10:29 AM EST, 01/07/2025 (MT Newswires) -- Shares of Bio-Techne ( TECH ) were up Tuesday morning after the life sciences company said it prevailed in a second claim of reverse engineering of its antibodies by Mitlenyi Biotec.

The company said a court in Germany ruled that Miltenyi Biotec commercialized antibodies developed based on information obtained by reverse engineering certain branded antibodies of Bio-Techne ( TECH ).

The court found that Miltenyi has been marketing and selling those antibodies and determined that Bio-Techne ( TECH ) is entitled to monetary damages related to sales of such antibodies, among other costs, Bio-Techne ( TECH ) said.

Miltenyi didn't immediately respond to MT Newswires' request for comment.

Price: 75.65, Change: +1.40, Percent Change: +1.89